ID   MPRO clone 2.1
AC   CVCL_5430
SY   MPRO Cell Line, Clone 2.1; MPRO C2.1; MPRO
DR   CLO; CLO_0007859
DR   ATCC; CRL-3604
DR   ATCC; CRL-11422
DR   Wikidata; Q54906516
RX   Patent=US5830760;
RX   PubMed=9808058;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11422.
CC   Transfected with: HGNC; 9864; RARA (with p.Gly404_Pro462 del = RARalpha403).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-11422; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 7
//
RX   Patent=US5830760;
RA   Tsai S., Collins S.J.;
RT   "Creating novel hematopoietic cell lines by expressing altered
RT   retinoic acid receptors.";
RL   Patent number US5830760, 03-Nov-1998.
//
RX   PubMed=9808058;
RA   Lawson N.D., Krause D.S., Berliner N.;
RT   "Normal neutrophil differentiation and secondary granule gene
RT   expression in the EML and MPRO cell lines.";
RL   Exp. Hematol. 26:1178-1185(1998).
//